---
annotation-target: 1-s2.0-S153561082200383X-main.pdf
---


>%%
>```annotation-json
>{"created":"2022-09-13T02:10:26.195Z","text":"层级","updated":"2022-09-13T02:10:26.195Z","document":{"title":"Cellular hierarchies predict drug response in acute myeloid leukemia","link":[{"href":"urn:x-pdf:e8395f4228d801f11c5c5b8628b0755a"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S153561082200383X-main.pdf"}],"documentFingerprint":"e8395f4228d801f11c5c5b8628b0755a"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S153561082200383X-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S153561082200383X-main.pdf","selector":[{"type":"TextPositionSelector","start":18,"end":29},{"type":"TextQuoteSelector","exact":"hierarchies","prefix":"0%200%300%400%SpotlightCellular ","suffix":" predict drug responsein acute m"}]}]}
>```
>%%
>*%%PREFIX%%0%200%300%400%SpotlightCellular%%HIGHLIGHT%% ==hierarchies== %%POSTFIX%%predict drug responsein acute m*
>%%LINK%%[[#^t50mnyi37ci|show annotation]]
>%%COMMENT%%
>层级
>%%TAGS%%
>
^t50mnyi37ci


>%%
>```annotation-json
>{"created":"2022-09-13T02:10:59.176Z","updated":"2022-09-13T02:10:59.176Z","document":{"title":"Cellular hierarchies predict drug response in acute myeloid leukemia","link":[{"href":"urn:x-pdf:e8395f4228d801f11c5c5b8628b0755a"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S153561082200383X-main.pdf"}],"documentFingerprint":"e8395f4228d801f11c5c5b8628b0755a"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S153561082200383X-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S153561082200383X-main.pdf","selector":[{"type":"TextPositionSelector","start":1353,"end":1497},{"type":"TextQuoteSelector","exact":"ntegrate both genomic and stem cell models ofacute myeloid leukemia (AML) by deconvoluting cellular hierarchies of more than 1,000 AML samples. ","prefix":"ine study, Zeng and colleagues i","suffix":"Thiswork introduces a framework "}]}]}
>```
>%%
>*%%PREFIX%%ine study, Zeng and colleagues i%%HIGHLIGHT%% ==ntegrate both genomic and stem cell models ofacute myeloid leukemia (AML) by deconvoluting cellular hierarchies of more than 1,000 AML samples.== %%POSTFIX%%Thiswork introduces a framework*
>%%LINK%%[[#^v112xc7ldhg|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^v112xc7ldhg


>%%
>```annotation-json
>{"created":"2022-09-13T02:13:25.739Z","updated":"2022-09-13T02:13:25.739Z","document":{"title":"Cellular hierarchies predict drug response in acute myeloid leukemia","link":[{"href":"urn:x-pdf:e8395f4228d801f11c5c5b8628b0755a"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S153561082200383X-main.pdf"}],"documentFingerprint":"e8395f4228d801f11c5c5b8628b0755a"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S153561082200383X-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S153561082200383X-main.pdf","selector":[{"type":"TextPositionSelector","start":2163,"end":2601},{"type":"TextQuoteSelector","exact":"In acute myeloid leukemia (AML), anaggressive hematologic malignancy withpoor clinical outcome, inter- and intrapa-tient heterogeneity is explained by twocomplementary models: a genomic modelthat is based on cytogenetic and muta-tional drivers present in leukemic cells (Pa-paemmanuil et al., 2016) and a stem cell model that reflects the non-genetic hierar-chical organization of AML similar to that ofhealthy hematopoiesis (Dick, 2008).","prefix":"erapy responses more accurately.","suffix":" Leu-kemia stem cells (LSCs), re"}]}]}
>```
>%%
>*%%PREFIX%%erapy responses more accurately.%%HIGHLIGHT%% ==In acute myeloid leukemia (AML), anaggressive hematologic malignancy withpoor clinical outcome, inter- and intrapa-tient heterogeneity is explained by twocomplementary models: a genomic modelthat is based on cytogenetic and muta-tional drivers present in leukemic cells (Pa-paemmanuil et al., 2016) and a stem cell model that reflects the non-genetic hierar-chical organization of AML similar to that ofhealthy hematopoiesis (Dick, 2008).== %%POSTFIX%%Leu-kemia stem cells (LSCs), re*
>%%LINK%%[[#^htmzh3f0cla|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^htmzh3f0cla


>%%
>```annotation-json
>{"created":"2022-09-13T02:17:10.768Z","updated":"2022-09-13T02:17:10.768Z","document":{"title":"Cellular hierarchies predict drug response in acute myeloid leukemia","link":[{"href":"urn:x-pdf:e8395f4228d801f11c5c5b8628b0755a"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S153561082200383X-main.pdf"}],"documentFingerprint":"e8395f4228d801f11c5c5b8628b0755a"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S153561082200383X-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S153561082200383X-main.pdf","selector":[{"type":"TextPositionSelector","start":3778,"end":4238},{"type":"TextQuoteSelector","exact":"Instead of analyzing several hun-dred AML patient samples by single-celltechnologies, the authors applied a two-step-process. First, authors re-analyzedexisting single-cell transcriptomic data of13,653 cells from 12 AML patients (vanGalen et al., 2019) to define 7 AMLsubpopulations ranging from immature(‘‘quiescent LSPCs,’’ ‘‘primed LSPCs,’’‘‘cycling LSPCs’’) to more differentiatedcell states (‘‘GMP-like,’’ ‘‘Pro-Mono-like,’’ ‘‘Mono-like,’’ or ‘‘cDC-like’’","prefix":"nses in AML (Zeng et al.,2022). ","suffix":"). In asecond step, the abundanc"}]}]}
>```
>%%
>*%%PREFIX%%nses in AML (Zeng et al.,2022).%%HIGHLIGHT%% ==Instead of analyzing several hun-dred AML patient samples by single-celltechnologies, the authors applied a two-step-process. First, authors re-analyzedexisting single-cell transcriptomic data of13,653 cells from 12 AML patients (vanGalen et al., 2019) to define 7 AMLsubpopulations ranging from immature(‘‘quiescent LSPCs,’’ ‘‘primed LSPCs,’’‘‘cycling LSPCs’’) to more differentiatedcell states (‘‘GMP-like,’’ ‘‘Pro-Mono-like,’’ ‘‘Mono-like,’’ or ‘‘cDC-like’’== %%POSTFIX%%). In asecond step, the abundanc*
>%%LINK%%[[#^5u5wpmo0cht|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^5u5wpmo0cht


>%%
>```annotation-json
>{"created":"2022-09-13T02:18:02.332Z","updated":"2022-09-13T02:18:02.332Z","document":{"title":"Cellular hierarchies predict drug response in acute myeloid leukemia","link":[{"href":"urn:x-pdf:e8395f4228d801f11c5c5b8628b0755a"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S153561082200383X-main.pdf"}],"documentFingerprint":"e8395f4228d801f11c5c5b8628b0755a"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S153561082200383X-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S153561082200383X-main.pdf","selector":[{"type":"TextPositionSelector","start":4245,"end":4747},{"type":"TextQuoteSelector","exact":"second step, the abundance of each ofthese cell types was estimated in morethan 1,000 AML patient samples usingCIBERSORTx (Newman et al., 2019), adeconvolution algorithm that employssingle-cell reference data to estimate thecellular composition of bulk gene expres-sion profiles. As a result, for each patient acharacteristic ‘‘hierarchy composition’’was calculated (Figure 1). The relevanceof this novel operationalization of thestem cell model of AML was comprehen-sively studied throughout the paper","prefix":"o-like,’’ or ‘‘cDC-like’’). In a","suffix":".Depending on the relative abund"}]}]}
>```
>%%
>*%%PREFIX%%o-like,’’ or ‘‘cDC-like’’). In a%%HIGHLIGHT%% ==second step, the abundance of each ofthese cell types was estimated in morethan 1,000 AML patient samples usingCIBERSORTx (Newman et al., 2019), adeconvolution algorithm that employssingle-cell reference data to estimate thecellular composition of bulk gene expres-sion profiles. As a result, for each patient acharacteristic ‘‘hierarchy composition’’was calculated (Figure 1). The relevanceof this novel operationalization of thestem cell model of AML was comprehen-sively studied throughout the paper== %%POSTFIX%%.Depending on the relative abund*
>%%LINK%%[[#^4is8u8j9nfr|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^4is8u8j9nfr


>%%
>```annotation-json
>{"created":"2022-09-13T02:19:23.033Z","updated":"2022-09-13T02:19:23.033Z","document":{"title":"Cellular hierarchies predict drug response in acute myeloid leukemia","link":[{"href":"urn:x-pdf:e8395f4228d801f11c5c5b8628b0755a"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S153561082200383X-main.pdf"}],"documentFingerprint":"e8395f4228d801f11c5c5b8628b0755a"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S153561082200383X-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S153561082200383X-main.pdf","selector":[{"type":"TextPositionSelector","start":5863,"end":6283},{"type":"TextQuoteSelector","exact":" The primi-tive-versus-mature axis instead was moreassociated with genetic driver mutationsand their combinations. For example,RAS mutations rather favored differentia-tion, whereas IDH mutations led to earlydifferentiation blocks. By applying hierar-chy deconvolution on well-annotatedAML samples at large scale, Zeng and col-leagues thus pioneered uniting bothgenomic and stem cell models of AMLinto a single framework","prefix":" tofavorable cytogenetic events.","suffix":".How can this framework and its "}]}]}
>```
>%%
>*%%PREFIX%%tofavorable cytogenetic events.%%HIGHLIGHT%% ==The primi-tive-versus-mature axis instead was moreassociated with genetic driver mutationsand their combinations. For example,RAS mutations rather favored differentia-tion, whereas IDH mutations led to earlydifferentiation blocks. By applying hierar-chy deconvolution on well-annotatedAML samples at large scale, Zeng and col-leagues thus pioneered uniting bothgenomic and stem cell models of AMLinto a single framework== %%POSTFIX%%.How can this framework and its*
>%%LINK%%[[#^ns2t2ui37uh|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^ns2t2ui37uh


>%%
>```annotation-json
>{"created":"2022-09-13T02:21:41.080Z","updated":"2022-09-13T02:21:41.080Z","document":{"title":"Cellular hierarchies predict drug response in acute myeloid leukemia","link":[{"href":"urn:x-pdf:e8395f4228d801f11c5c5b8628b0755a"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S153561082200383X-main.pdf"}],"documentFingerprint":"e8395f4228d801f11c5c5b8628b0755a"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S153561082200383X-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S153561082200383X-main.pdf","selector":[{"type":"TextPositionSelector","start":8257,"end":8525},{"type":"TextQuoteSelector","exact":"predict the ef-fect of GO treatment for event-free andrelapse-free survival. It remains to beshown whether LinClass-7 can serve as auseful predictive biomarker for other thera-pies, including approved but still noveldrug combinations, such as venetoclaxand azacytidine","prefix":"e Lin-Class-7 score was able to ","suffix":".The authors also evaluated the "}]}]}
>```
>%%
>*%%PREFIX%%e Lin-Class-7 score was able to%%HIGHLIGHT%% ==predict the ef-fect of GO treatment for event-free andrelapse-free survival. It remains to beshown whether LinClass-7 can serve as auseful predictive biomarker for other thera-pies, including approved but still noveldrug combinations, such as venetoclaxand azacytidine== %%POSTFIX%%.The authors also evaluated the*
>%%LINK%%[[#^prn17euq9fi|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^prn17euq9fi
